Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial. (2010)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3851/IMP1695

PubMed Identifier: 21149918

Publication URI: http://europepmc.org/abstract/MED/21149918

Type: Journal Article/Review

Volume: 15

Parent Publication: Antiviral therapy

Issue: 8

ISSN: 1359-6535